NCT02145689View on ClinicalTrials.gov

Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Muscle SpasticityStroke
Interventions
BIOLOGICAL

onabotulinumtoxinA

Up to 4 treatments of onabotulinumtoxinA injected into muscles of the study limb on fulfillment of the retreatment criteria.

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY